Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Central European Media Enterprises Ltd. Reports Results for the Three Months Ended March 31, 2019

Published

on

Reading Time: 11 minutes

– Net revenues decreased 7% at actual rates but increased 2% at
constant rates to US$ 146.6 million –

– Operating income increased 12% at actual rates and 23% at constant
rates to US$ 27.6 million –

– OIBDA increased 8% at actual rates and 18% at constant rates to US$
38.1 million –

HAMILTON, Bermuda–(BUSINESS WIRE)–Central European Media Enterprises Ltd. (“CME” or the “Company”)
(NASDAQ/Prague Stock Exchange – CETV) today announced financial results
for the three months ended March 31, 2019.

Operational and financial highlights:

  • TV advertising revenues decreased 10% at actual rates and 2% at
    constant rates in the quarter. In the first four months of 2019, which
    normalizes the phasing of spending around Easter, TV ad revenues are
    estimated to have increased 3% at constant rates compared to the same
    period in 2018.
  • Carriage fees and subscription revenues increased 4% at actual rates
    and 12% at constant rates in the first quarter.
  • Costs charged in arriving at OIBDA decreased 11% at actual rates and
    3% at constant rates.
  • OIBDA margin increased by 360 basis points to 26%.
  • Cash generated from continuing operating activities increased 34% at
    actual rates to US$ 96.0 million.
  • Unlevered free cash flow increased 33% at actual rates to US$ 94.7
    million.
  • CME repaid EUR 60 million of debt from cash generated by the business,
    which together with the improvement in our operations reduced our net
    leverage ratio to 3.0x at the end of March from 3.5x at the start of
    the year.

Michael Del Nin, Co-Chief Executive Officer, commented: “The year has
gotten off to an outstanding start, exceeding our previous expectations
to such an extent that we are raising our guidance for 2019. With the
highest Q1 margin in more than a decade, an 18% improvement in
like-for-like OIBDA, and a more than 30% surge in unlevered free cash
flow, these are among the best Q1 results in the history of the company.
Furthermore, they are bolstered by around 20% growth in TV ad revenues
in our two largest markets in April, pushing year-to-date sales well
into positive territory after the first quarter was impacted by both
sector taxes in Romania and the phasing of spending related to the
timing of Easter this year.”

Christoph Mainusch, Co-Chief Executive Officer, added: “With the
successful launch of the spring season during the first quarter, our
main channel in four countries increased year-to-date audience share in
both prime time and all day. Carriage fees have transformed the
predictability and profitability of several of our businesses, with four
segments now seeing margins of more than 25% in Q1. Facing various
headwinds in the quarter, we grew our TV ad revenues in three segments,
and we increased market share in four of five countries.”

In this release we refer to several non-GAAP financial measures,
including OIBDA, OIBDA margin, free cash flow, unlevered free cash flow
and constant currency percentage movements. Please see “Non-GAAP
Financial Measures” below for additional information, including
definitions and reconciliations to US GAAP financial measures.

Consolidated results for the three months ended March 31, 2019 and 2018
were:

(US$ 000’s, except per share data)     For the Three Months Ended March 31,

(unaudited)

 

2019

       

2018

     

% Actual

   

% Lfl (1)

Net revenues $ 146,559 $ 156,709 (6.5)% 1.6%
Operating income 27,637 24,581 12.4% 23.2%
Operating margin 18.9 % 15.7 % 3.2 p.p. 3.3 p.p.
OIBDA 38,057 35,324 7.7% 17.7%
OIBDA margin 26.0 % 22.5 % 3.5 p.p. 3.6 p.p.
Income from continuing operations 11,751 6,756 73.9% 96.6%
Income from continuing operations per share – basic 0.03 0.02 86.9% 127.0%
Income from continuing operations per share – diluted $ 0.03 $ 0.01 144.8% 197.3%
(1) % Lfl (like-for-like) variance reflects the impact of
applying the current period average exchange rates to the prior
period revenues and costs.
 

Teleconference and Audio Webcast Details

CME will host a teleconference and audio webcast to discuss its first
quarter results on Tuesday, April 30, 2019 at 9 a.m. New York time (2
p.m. London and 3 p.m. Prague time). The audio webcast and
teleconference will refer to presentation slides which will be available
on CME’s website at www.cme.net
prior to the call.

To access the teleconference, U.S. and international callers may dial
+1-647-689-5402 ten minutes prior to the start time and reference
conference ID 2273725. The conference call will also be audio webcasted
via www.cme.net.
It can be heard on iPads, iPhones and a range of devices supporting
Android and Windows operating systems.

A digital audio replay of the webcast will be available for two weeks
following the call at www.cme.net.

Forward-Looking and Cautionary Statements

This press release contains forward-looking statements. For all
forward-looking statements, we claim the protection of the safe harbor
for forward-looking statements contained in the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are inherently
subject to risks and uncertainties, many of which cannot be predicted
with accuracy or are otherwise beyond our control and some of which
might not even be anticipated.
Forward-looking statements reflect
our current views with respect to future events and because our business
is subject to such risks and uncertainties, actual results, our
strategic plan, our financial position, results of operations and cash
flows could differ materially from those described in or contemplated by
the forward-looking statements.

Important factors that contribute to such risks include, but are not
limited to, those factors set forth under “Risk Factors” in our
Quarterly Report on Form 10-Q for the period ended March 31, 2019 as
well as the following: the effect of changes in global and regional
economic conditions; the impact of ending the quantitative easing
program implemented by the European Central Bank; the economic,
political and monetary impacts of Brexit in our markets; the outcome of
our strategic review and its impact on our business; the impact of
changes in local tax legislation and the timing of public holidays on
advertising spending; levels of television advertising spending and the
rate of development of the advertising markets in the countries in which
we operate; our ability to refinance our existing indebtedness; the
extent to which our debt service obligations and covenants may restrict
our business; our exposure to additional tax liabilities as well as
liabilities resulting from regulatory or legal proceedings initiated
against us; our success in continuing our initiatives to diversify and
enhance our revenue streams; our ability to make cost-effective
investments in our television businesses, including investments in
programming; our ability to develop and acquire necessary programming
and attract audiences; and changes in the political and regulatory
environments where we operate and in the application of relevant laws
and regulations.

The foregoing review of important factors should not be construed as
exhaustive. For a more detailed description of these uncertainties and
other factors, please see the “Risk Factors” and “Forward-looking
Statements” sections in CME’s Quarterly Report on Form 10-Q for the
period ended March 31, 2019. We undertake no obligation to publicly
update or review any forward-looking statements, whether as a result of
new information, future developments or otherwise.

This press release should be read in conjunction with our Quarterly
Report on Form 10-Q for the period ended March 31, 2019, which was filed
with the Securities and Exchange Commission on April 30, 2019.

We make available free of charge on our website at www.cme.net
our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K and amendments to those reports as soon as
reasonably practicable after we electronically file such material with,
or furnish it to, the Securities and Exchange Commission. Please note
that we may announce material information using SEC filings, press
releases, public conference calls, webcasts and posts to the Investors
section of our website, www.cme.net.
In the future, we will continue to use these channels to communicate
important information about CME and our operations. Information that we
post on our website could be deemed material. Therefore, we encourage
investors, the media, our customers and others interested in CME to
review the information we post at www.cme.net.

CME is a media and entertainment company operating leading businesses in
five Central and Eastern European markets with an aggregate population
of approximately 45 million people. CME’s operations broadcast 30
television channels in Bulgaria (bTV, bTV Cinema, bTV Comedy, bTV
Action, bTV Lady and Ring), the Czech Republic (Nova, Nova 2, Nova
Cinema, Nova Sport 1, Nova Sport 2, Nova International, Nova Action and
Nova Gold), Romania (PRO TV, PRO 2, PRO X, PRO GOLD, PRO CINEMA, PRO TV
International and PRO TV Chisinau), the Slovak Republic (TV Markíza,
Markíza International, Doma and Dajto) and Slovenia (POP TV, Kanal A,
Brio, Oto and Kino). CME is traded on the NASDAQ Global Select Market
and the Prague Stock Exchange under the ticker symbol “CETV”.

 

CENTRAL EUROPEAN MEDIA ENTERPRISES LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(US$ 000’s, except share and per share data)

(unaudited)

 
For the Three Months Ended March 31,
 

2019

     

2018

 
Net revenues $ 146,559 $ 156,709
Operating expenses:
Content costs 70,360 78,460
Other operating costs 13,248 14,467
Depreciation of property, plant and equipment 8,226 8,387
Amortization of broadcast licenses and other intangibles 2,194   2,356  
Cost of revenues 94,028 103,670
Selling, general and administrative expenses 24,894   28,458  
Operating income 27,637 24,581
Interest expense (8,242 ) (17,818 )
Other non-operating (expense) / income, net (3,097 ) 4,208  
Income before tax 16,298 10,971
Provision for income taxes (4,547 ) (4,215 )
Income from continuing operations 11,751 6,756
Income from discontinued operations, net of tax   316  
Net income 11,751 7,072
Net loss attributable to noncontrolling interests 7   178  
Net income attributable to CME Ltd. $ 11,758   $ 7,250  
 
PER SHARE DATA:
Net income per share:
Continuing operations — basic $ 0.03 $ 0.02
Continuing operations — diluted 0.03 0.01
Discontinued operations — basic 0.00
Discontinued operations — diluted 0.00
Attributable to CME Ltd. — basic 0.03 0.02
Attributable to CME Ltd. — diluted $ 0.03 $ 0.01
 
Weighted average common shares used in computing per share
amounts (000’s):
Basic 264,199 158,039
Diluted 265,211 241,905
 
 

CENTRAL EUROPEAN MEDIA ENTERPRISES LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(US$ 000’s)

(unaudited)

   
March 31, 2019 December 31, 2018
ASSETS
Cash and cash equivalents $ 80,032 $ 62,031
Other current assets 263,098   312,062  
Total current assets 343,130 374,093
Property, plant and equipment, net 110,347 117,604
Goodwill and other intangible assets, net 968,225 984,256
Other non-current assets 23,967   12,408  
Total assets $ 1,445,669   $ 1,488,361  
 
LIABILITIES AND EQUITY
Accounts payable and accrued liabilities $ 127,222 $ 120,468
Current portion of long-term debt and other financing arrangements 5,802 5,545
Other current liabilities 38,453   13,679  
Total current liabilities 171,477 139,692
Long-term debt and other financing arrangements 700,694 782,685
Other non-current liabilities 81,526   67,293  
Total liabilities $ 953,697   $ 989,670  
 
Series B Convertible Redeemable Preferred Stock $ 269,370 $ 269,370
 
EQUITY
Common Stock $ 20,262 $ 20,228
Additional paid-in capital 2,004,188 2,003,518
Accumulated deficit (1,566,318 ) (1,578,076 )
Accumulated other comprehensive loss (235,961 ) (216,650 )
Total CME Ltd. shareholders’ equity 222,171 229,020
Noncontrolling interests 431   301  
Total equity 222,602   229,321  
Total liabilities and equity $ 1,445,669   $ 1,488,361  
 
 

CENTRAL EUROPEAN MEDIA ENTERPRISES LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(US$ 000’s)

(unaudited)

     
For the Three Months
Ended March 31,
 

2019

     

2018

 
Net cash generated from continuing operating activities $ 96,009 $ 71,495
Net cash used in continuing investing activities (4,359 ) (5,353 )
Net cash used in continuing financing activities (71,736 ) (60,526 )
Net cash provided by discontinued operations 9,554
Impact of exchange rate fluctuations on cash and cash equivalents (1,913 ) 2,515  
Net increase in cash and cash equivalents $ 18,001   $ 17,685  
 
Supplemental disclosure of cash flow information:
Cash paid for interest (including guarantee fees) $ 3,093 $ 4,883
Cash paid for income taxes, net of refunds $ 6,318 $ 4,120
 
Supplemental disclosure of non-cash financing activities:
Accretion on Series B Convertible Redeemable Preferred Stock $ $ 2,447
 

Segment Data

We manage our business on a geographical basis, with five reporting
segments: Bulgaria, the Czech Republic, Romania, the Slovak Republic and
Slovenia. These segments reflect how CME Ltd.’s operating performance is
evaluated by our chief operating decision makers, who we have identified
as our co-Chief Executive Officers, how operations are managed by
segment managers, and the structure of our internal financial reporting.

We evaluate our consolidated results and the performance of our segments
based on net revenues and OIBDA. Intersegment revenues and profits have
been eliminated in consolidation.

Below are tables showing our net revenues and OIBDA by segment for the
three months ended March 31, 2019 and 2018:

(US$ 000’s)       For the Three Months Ended March 31,

(unaudited)

 

2019

     

2018

   

% Actual

 

% Lfl (1)

Net revenues

Bulgaria $ 19,293 $ 19,433 (0.7 )% 6.9 %
Czech Republic 50,316 51,534 (2.4 )% 6.4 %
Romania 38,810 45,961 (15.6 )% (7.5 )%
Slovak Republic 21,332 22,953 (7.1 )% 0.1 %
Slovenia 17,850 17,530 1.8 % 9.6 %
Intersegment revenues (1,042 ) (702 ) NM (2) NM (2)
Total net revenues $ 146,559   $ 156,709   (6.5 )% 1.6 %
 
(US$ 000’s) For the Three Months Ended March 31,

(unaudited)

 

2019

   

2018

 

% Act

% Lfl (1)

OIBDA

Bulgaria $ 6,121 $ 2,981 105.3 % 121.2 %
Czech Republic 14,947 15,370 (2.8 )% 6.1 %
Romania 17,533 18,893 (7.2 )% 1.7 %
Slovak Republic 1,729 1,103 56.8 % 71.5 %
Slovenia 4,931 4,653 6.0 % 14.1 %
Elimination 48   16   NM (2) NM (2)
Total Operating Segments 45,309 43,016 5.3 % 14.9 %
Corporate (7,252 ) (7,692 ) 5.7 % (2.2 )%
Total OIBDA $ 38,057   $ 35,324   7.7 % 17.7 %
 
(1) % Lfl (like-for-like) variance reflects the impact of
applying the current period average exchange rates to the prior
period revenues and costs.

(2) Number is not meaningful.

 

Non-GAAP Financial Measures

In this release we refer to several non-GAAP financial measures,
including OIBDA, OIBDA margin, free cash flow and unlevered free cash
flow. We believe that each of these metrics is useful to investors for
the reasons outlined below. Non-GAAP financial measures may not be
comparable to similar measures reported by other companies. Non-GAAP
financial measures should be evaluated in conjunction with, and are not
a substitute for, US GAAP financial measures.

We evaluate our consolidated results and the performance of our segments
based on net revenues and OIBDA. We believe OIBDA is useful to investors
because it provides a meaningful representation of our performance, as
it excludes certain items that do not impact either our cash flows or
the operating results of our operations. OIBDA and unlevered free cash
flow are also used as components in determining management bonuses.

OIBDA includes amortization and impairment of program rights and is
calculated as operating income / loss before depreciation, amortization
of intangible assets and impairments of assets and certain unusual or
infrequent items that are not considered by our co-Chief Executive
Officers when evaluating our performance. Our key performance measure of
the efficiency of our consolidated operations and our segments is OIBDA
margin. We define OIBDA margin as the ratio of OIBDA to net revenues.

Following a repricing of our Guarantee Fees in March 2017 and April
2018, we pay interest and related Guarantee Fees on our outstanding
indebtedness in cash. In addition to this obligation to pay Guarantee
Fees in cash, we expect to use cash generated by the business to pay
certain Guarantee Fees that were previously paid in kind. These cash
payments are all reflected in free cash flow; accordingly we believe
unlevered free cash flow, defined as free cash flow before cash payments
for interest and Guarantee Fees, best illustrates the cash generated by
our operations when comparing periods. We define free cash flow as net
cash generated from continuing operating activities less purchases of
property, plant and equipment, net of disposals of property, plant and
equipment and excluding the cash impact of certain unusual or infrequent
items that are not included in costs charged in arriving at OIBDA
because they are not considered by our co-Chief Executive Officers when
evaluating performance. For additional information regarding our
business segments, see Item 1, Note 19, “Segment Data” in our Form 10-Q.

While our reporting currency is the dollar, our consolidated revenues
and costs are divided across a range of European currencies and CME
Ltd.’s function currency is the Euro. Given the significant movement of
the currencies in the markets in which we operate against the dollar, we
believe that it is useful to provide percentage movements based on
actual percentage movements (“% Act”), which includes the effect of
foreign exchange, as well as like-for-like percentage movements (“%
Lfl”). The like-for-like percentage movement references reflect the
impact of applying the current period average exchange rates to the
prior period revenues and costs. Since the difference between
like-for-like and actual percentage movements is solely the impact of
movements in foreign exchange rates, our discussion in this release
includes constant currency percentage movements in order to highlight
those factors influencing operational performance. The incremental
impact of foreign exchange rates is presented in the tables accompanying
such analysis.

   
(US$ 000’s) For the Three Months Ended March 31,
(unaudited) 2019     2018  
Operating income $ 27,637 $ 24,581
Depreciation of property, plant and equipment 8,226 8,387
Amortization of intangible assets 2,194   2,356  
Total OIBDA $ 38,057   $ 35,324  
 
(US$ 000’s) For the Three Months Ended March 31,
(unaudited) 2019   2018  
Net cash generated from continuing operating activities $ 96,009 $ 71,495
Capital expenditures, net of proceeds from disposals (4,359 ) (5,353 )
Free cash flow 91,650 66,142
Cash paid for interest (including mandatory cash-pay guarantee fees) 3,093   4,883  
Unlevered free cash flow from continuing operating activities $ 94,743   $ 71,025  

Contacts

For additional information, please visit www.cme.net
or contact:
Mark Kobal
Head of Investor Relations
Central
European Media Enterprises
+420 242 465 576
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania